Link → Precursors to Corneal Transplant Failure; Patients Who Skip Glaucoma Treatment
Excerpt: To learn more about adherence, a team of researchers from Johns Hopkins and University of Pennsylvania Schools of Medicine gave glaucoma patients a prostaglandin eyedrop medication at no cost and monitored use with an electronic device. “Eighty-six of our 196 study patients (44 percent) took their medication less than 75 percent of the time. A combined analysis found the most important factors were age (younger and older patients were less adherent), African-American ethnicity, and poorer overall health.
